nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—systemic scleroderma	0.182	0.292	CbGbCtD
Furosemide—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0747	0.119	CbGbCtD
Furosemide—SLC22A6—Captopril—systemic scleroderma	0.0694	0.111	CbGbCtD
Furosemide—ALB—Captopril—systemic scleroderma	0.0591	0.0945	CbGbCtD
Furosemide—SLC22A11—Methotrexate—systemic scleroderma	0.0541	0.0865	CbGbCtD
Furosemide—ALB—Mycophenolate mofetil—systemic scleroderma	0.0465	0.0744	CbGbCtD
Furosemide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.0407	0.497	CbGeAlD
Furosemide—ALB—Prednisone—systemic scleroderma	0.0372	0.0595	CbGbCtD
Furosemide—SLC22A8—Methotrexate—systemic scleroderma	0.0315	0.0503	CbGbCtD
Furosemide—ABCC2—Methotrexate—systemic scleroderma	0.03	0.0479	CbGbCtD
Furosemide—SLC22A6—Methotrexate—systemic scleroderma	0.0219	0.035	CbGbCtD
Furosemide—ALB—Methotrexate—systemic scleroderma	0.0187	0.0298	CbGbCtD
Furosemide—CA7—digestive system—systemic scleroderma	0.00205	0.0251	CbGeAlD
Furosemide—CA12—connective tissue—systemic scleroderma	0.00185	0.0226	CbGeAlD
Furosemide—CA9—digestive system—systemic scleroderma	0.0018	0.022	CbGeAlD
Furosemide—SLCO2A1—skin of body—systemic scleroderma	0.00177	0.0216	CbGeAlD
Furosemide—PGD—connective tissue—systemic scleroderma	0.00175	0.0214	CbGeAlD
Furosemide—CA9—tendon—systemic scleroderma	0.00172	0.021	CbGeAlD
Furosemide—CA14—tendon—systemic scleroderma	0.00163	0.0199	CbGeAlD
Furosemide—PGD—smooth muscle tissue—systemic scleroderma	0.0016	0.0195	CbGeAlD
Furosemide—SLC22A11—digestive system—systemic scleroderma	0.00158	0.0193	CbGeAlD
Furosemide—PGD—skin of body—systemic scleroderma	0.00158	0.0193	CbGeAlD
Furosemide—SLCO2A1—tendon—systemic scleroderma	0.00135	0.0165	CbGeAlD
Furosemide—CA12—digestive system—systemic scleroderma	0.00133	0.0163	CbGeAlD
Furosemide—PGD—digestive system—systemic scleroderma	0.00126	0.0154	CbGeAlD
Furosemide—PGD—tendon—systemic scleroderma	0.0012	0.0147	CbGeAlD
Furosemide—SLCO2A1—lung—systemic scleroderma	0.00118	0.0145	CbGeAlD
Furosemide—CA5B—tendon—systemic scleroderma	0.00114	0.0139	CbGeAlD
Furosemide—CA12—lung—systemic scleroderma	0.00111	0.0136	CbGeAlD
Furosemide—CA1—digestive system—systemic scleroderma	0.00106	0.0129	CbGeAlD
Furosemide—PGD—lung—systemic scleroderma	0.00105	0.0129	CbGeAlD
Furosemide—CA5B—lung—systemic scleroderma	0.000999	0.0122	CbGeAlD
Furosemide—CA2—connective tissue—systemic scleroderma	0.000948	0.0116	CbGeAlD
Furosemide—CA1—lung—systemic scleroderma	0.000882	0.0108	CbGeAlD
Furosemide—ABCC2—digestive system—systemic scleroderma	0.000869	0.0106	CbGeAlD
Furosemide—CA2—smooth muscle tissue—systemic scleroderma	0.000867	0.0106	CbGeAlD
Furosemide—CA2—skin of body—systemic scleroderma	0.000856	0.0105	CbGeAlD
Furosemide—SLC22A5—skin of body—systemic scleroderma	0.000842	0.0103	CbGeAlD
Furosemide—ABCC2—tendon—systemic scleroderma	0.000827	0.0101	CbGeAlD
Furosemide—CA4—digestive system—systemic scleroderma	0.000826	0.0101	CbGeAlD
Furosemide—CA4—tendon—systemic scleroderma	0.000786	0.0096	CbGeAlD
Furosemide—CA4—lung—systemic scleroderma	0.00069	0.00842	CbGeAlD
Furosemide—CA2—digestive system—systemic scleroderma	0.000685	0.00836	CbGeAlD
Furosemide—SLC22A5—digestive system—systemic scleroderma	0.000674	0.00823	CbGeAlD
Furosemide—CA2—tendon—systemic scleroderma	0.000652	0.00796	CbGeAlD
Furosemide—SLC22A5—tendon—systemic scleroderma	0.000641	0.00783	CbGeAlD
Furosemide—CA2—lung—systemic scleroderma	0.000572	0.00699	CbGeAlD
Furosemide—SLC22A5—lung—systemic scleroderma	0.000563	0.00687	CbGeAlD
Furosemide—Diarrhoea—Mometasone—systemic scleroderma	0.000271	0.000927	CcSEcCtD
Furosemide—Hypokalaemia—Prednisone—systemic scleroderma	0.000271	0.000927	CcSEcCtD
Furosemide—Leukopenia—Lisinopril—systemic scleroderma	0.00027	0.000924	CcSEcCtD
Furosemide—Shock—Mycophenolic acid—systemic scleroderma	0.000269	0.00092	CcSEcCtD
Furosemide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000268	0.000917	CcSEcCtD
Furosemide—Hypotension—Leflunomide—systemic scleroderma	0.000268	0.000916	CcSEcCtD
Furosemide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000268	0.000916	CcSEcCtD
Furosemide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000266	0.000909	CcSEcCtD
Furosemide—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000905	CcSEcCtD
Furosemide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000265	0.000904	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000264	0.000902	CcSEcCtD
Furosemide—Muscular weakness—Prednisone—systemic scleroderma	0.000263	0.000898	CcSEcCtD
Furosemide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000262	0.000896	CcSEcCtD
Furosemide—Anorexia—Mycophenolic acid—systemic scleroderma	0.000261	0.000892	CcSEcCtD
Furosemide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000891	CcSEcCtD
Furosemide—Abdominal distension—Prednisone—systemic scleroderma	0.000259	0.000886	CcSEcCtD
Furosemide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000886	CcSEcCtD
Furosemide—Paraesthesia—Leflunomide—systemic scleroderma	0.000258	0.00088	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000257	0.000879	CcSEcCtD
Furosemide—Hypotension—Mycophenolic acid—systemic scleroderma	0.000256	0.000874	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000255	0.000873	CcSEcCtD
Furosemide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00087	CcSEcCtD
Furosemide—Lethargy—Methotrexate—systemic scleroderma	0.000254	0.000868	CcSEcCtD
Furosemide—Pancreatitis—Prednisone—systemic scleroderma	0.000252	0.000863	CcSEcCtD
Furosemide—Vomiting—Mometasone—systemic scleroderma	0.000252	0.000861	CcSEcCtD
Furosemide—Dry mouth—Lisinopril—systemic scleroderma	0.000251	0.00086	CcSEcCtD
Furosemide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00025	0.000856	CcSEcCtD
Furosemide—Rash—Mometasone—systemic scleroderma	0.00025	0.000854	CcSEcCtD
Furosemide—Asthenia—Captopril—systemic scleroderma	0.00025	0.000854	CcSEcCtD
Furosemide—Dermatitis—Mometasone—systemic scleroderma	0.00025	0.000853	CcSEcCtD
Furosemide—Decreased appetite—Leflunomide—systemic scleroderma	0.000249	0.000852	CcSEcCtD
Furosemide—Confusional state—Lisinopril—systemic scleroderma	0.000249	0.00085	CcSEcCtD
Furosemide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000248	0.000849	CcSEcCtD
Furosemide—Headache—Mometasone—systemic scleroderma	0.000248	0.000849	CcSEcCtD
Furosemide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000248	0.000847	CcSEcCtD
Furosemide—Fatigue—Leflunomide—systemic scleroderma	0.000247	0.000845	CcSEcCtD
Furosemide—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000246	0.000843	CcSEcCtD
Furosemide—Pruritus—Captopril—systemic scleroderma	0.000246	0.000842	CcSEcCtD
Furosemide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000246	0.00084	CcSEcCtD
Furosemide—Pain—Leflunomide—systemic scleroderma	0.000245	0.000839	CcSEcCtD
Furosemide—Constipation—Leflunomide—systemic scleroderma	0.000245	0.000839	CcSEcCtD
Furosemide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000836	CcSEcCtD
Furosemide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000243	0.000832	CcSEcCtD
Furosemide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000831	CcSEcCtD
Furosemide—Shock—Lisinopril—systemic scleroderma	0.000243	0.000829	CcSEcCtD
Furosemide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000241	0.000825	CcSEcCtD
Furosemide—Abdominal pain—Azathioprine—systemic scleroderma	0.00024	0.000821	CcSEcCtD
Furosemide—Body temperature increased—Azathioprine—systemic scleroderma	0.00024	0.000821	CcSEcCtD
Furosemide—Skin disorder—Lisinopril—systemic scleroderma	0.000239	0.000818	CcSEcCtD
Furosemide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000238	0.000815	CcSEcCtD
Furosemide—Diarrhoea—Captopril—systemic scleroderma	0.000238	0.000814	CcSEcCtD
Furosemide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000238	0.000813	CcSEcCtD
Furosemide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000813	CcSEcCtD
Furosemide—Irritability—Methotrexate—systemic scleroderma	0.000238	0.000812	CcSEcCtD
Furosemide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00081	CcSEcCtD
Furosemide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000236	0.000808	CcSEcCtD
Furosemide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000236	0.000808	CcSEcCtD
Furosemide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000236	0.000806	CcSEcCtD
Furosemide—Nausea—Mometasone—systemic scleroderma	0.000235	0.000805	CcSEcCtD
Furosemide—Anorexia—Lisinopril—systemic scleroderma	0.000235	0.000803	CcSEcCtD
Furosemide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000235	0.000802	CcSEcCtD
Furosemide—Pain—Mycophenolic acid—systemic scleroderma	0.000234	0.0008	CcSEcCtD
Furosemide—Constipation—Mycophenolic acid—systemic scleroderma	0.000234	0.0008	CcSEcCtD
Furosemide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000232	0.000794	CcSEcCtD
Furosemide—Hypotension—Lisinopril—systemic scleroderma	0.00023	0.000787	CcSEcCtD
Furosemide—Dizziness—Captopril—systemic scleroderma	0.00023	0.000787	CcSEcCtD
Furosemide—Urticaria—Leflunomide—systemic scleroderma	0.000228	0.000779	CcSEcCtD
Furosemide—Abdominal pain—Leflunomide—systemic scleroderma	0.000227	0.000775	CcSEcCtD
Furosemide—Body temperature increased—Leflunomide—systemic scleroderma	0.000227	0.000775	CcSEcCtD
Furosemide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000226	0.000771	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000224	0.000766	CcSEcCtD
Furosemide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000224	0.000765	CcSEcCtD
Furosemide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000224	0.000765	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000765	CcSEcCtD
Furosemide—Paraesthesia—Lisinopril—systemic scleroderma	0.000221	0.000757	CcSEcCtD
Furosemide—Vomiting—Captopril—systemic scleroderma	0.000221	0.000756	CcSEcCtD
Furosemide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000753	CcSEcCtD
Furosemide—Rash—Captopril—systemic scleroderma	0.000219	0.00075	CcSEcCtD
Furosemide—Dermatitis—Captopril—systemic scleroderma	0.000219	0.000749	CcSEcCtD
Furosemide—Somnolence—Lisinopril—systemic scleroderma	0.000219	0.000749	CcSEcCtD
Furosemide—Headache—Captopril—systemic scleroderma	0.000218	0.000745	CcSEcCtD
Furosemide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000744	CcSEcCtD
Furosemide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000216	0.000739	CcSEcCtD
Furosemide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000216	0.000739	CcSEcCtD
Furosemide—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000738	CcSEcCtD
Furosemide—Decreased appetite—Lisinopril—systemic scleroderma	0.000214	0.000732	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—systemic scleroderma	0.000213	0.000728	CcSEcCtD
Furosemide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000213	0.000727	CcSEcCtD
Furosemide—Fatigue—Lisinopril—systemic scleroderma	0.000213	0.000726	CcSEcCtD
Furosemide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000726	CcSEcCtD
Furosemide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000724	CcSEcCtD
Furosemide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000723	CcSEcCtD
Furosemide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000211	0.000722	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—systemic scleroderma	0.000211	0.000721	CcSEcCtD
Furosemide—Pain—Lisinopril—systemic scleroderma	0.000211	0.000721	CcSEcCtD
Furosemide—Constipation—Lisinopril—systemic scleroderma	0.000211	0.000721	CcSEcCtD
Furosemide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000717	CcSEcCtD
Furosemide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000714	CcSEcCtD
Furosemide—Diarrhoea—Azathioprine—systemic scleroderma	0.000208	0.00071	CcSEcCtD
Furosemide—Nausea—Captopril—systemic scleroderma	0.000207	0.000707	CcSEcCtD
Furosemide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000704	CcSEcCtD
Furosemide—Asthenia—Leflunomide—systemic scleroderma	0.000206	0.000704	CcSEcCtD
Furosemide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000203	0.000694	CcSEcCtD
Furosemide—Pruritus—Leflunomide—systemic scleroderma	0.000203	0.000694	CcSEcCtD
Furosemide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00069	CcSEcCtD
Furosemide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000202	0.000689	CcSEcCtD
Furosemide—Dizziness—Azathioprine—systemic scleroderma	0.000201	0.000687	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000196	0.000671	CcSEcCtD
Furosemide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000196	0.000671	CcSEcCtD
Furosemide—Diarrhoea—Leflunomide—systemic scleroderma	0.000196	0.000671	CcSEcCtD
Furosemide—Urticaria—Lisinopril—systemic scleroderma	0.000196	0.000669	CcSEcCtD
Furosemide—Abdominal pain—Lisinopril—systemic scleroderma	0.000195	0.000666	CcSEcCtD
Furosemide—Body temperature increased—Lisinopril—systemic scleroderma	0.000195	0.000666	CcSEcCtD
Furosemide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000663	CcSEcCtD
Furosemide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000194	0.000662	CcSEcCtD
Furosemide—Vomiting—Azathioprine—systemic scleroderma	0.000193	0.00066	CcSEcCtD
Furosemide—Eye disorder—Prednisone—systemic scleroderma	0.000193	0.000658	CcSEcCtD
Furosemide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000656	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—systemic scleroderma	0.000192	0.000656	CcSEcCtD
Furosemide—Rash—Azathioprine—systemic scleroderma	0.000192	0.000655	CcSEcCtD
Furosemide—Dermatitis—Azathioprine—systemic scleroderma	0.000191	0.000654	CcSEcCtD
Furosemide—Headache—Azathioprine—systemic scleroderma	0.00019	0.00065	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00019	0.00065	CcSEcCtD
Furosemide—Dizziness—Leflunomide—systemic scleroderma	0.00019	0.000648	CcSEcCtD
Furosemide—Renal failure—Methotrexate—systemic scleroderma	0.000189	0.000645	CcSEcCtD
Furosemide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000642	CcSEcCtD
Furosemide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000187	0.00064	CcSEcCtD
Furosemide—Angiopathy—Prednisone—systemic scleroderma	0.000187	0.000639	CcSEcCtD
Furosemide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000637	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—systemic scleroderma	0.000186	0.000636	CcSEcCtD
Furosemide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000631	CcSEcCtD
Furosemide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000631	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—systemic scleroderma	0.000184	0.000629	CcSEcCtD
Furosemide—Sweating—Methotrexate—systemic scleroderma	0.000184	0.000629	CcSEcCtD
Furosemide—Vomiting—Leflunomide—systemic scleroderma	0.000182	0.000623	CcSEcCtD
Furosemide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000182	0.000621	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000181	0.00062	CcSEcCtD
Furosemide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000181	0.000619	CcSEcCtD
Furosemide—Rash—Leflunomide—systemic scleroderma	0.000181	0.000618	CcSEcCtD
Furosemide—Dermatitis—Leflunomide—systemic scleroderma	0.000181	0.000618	CcSEcCtD
Furosemide—Nausea—Azathioprine—systemic scleroderma	0.00018	0.000617	CcSEcCtD
Furosemide—Headache—Leflunomide—systemic scleroderma	0.00018	0.000614	CcSEcCtD
Furosemide—Malnutrition—Prednisone—systemic scleroderma	0.000179	0.000613	CcSEcCtD
Furosemide—Erythema—Prednisone—systemic scleroderma	0.000179	0.000613	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000179	0.000612	CcSEcCtD
Furosemide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000608	CcSEcCtD
Furosemide—Asthenia—Lisinopril—systemic scleroderma	0.000177	0.000605	CcSEcCtD
Furosemide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000604	CcSEcCtD
Furosemide—Pruritus—Lisinopril—systemic scleroderma	0.000174	0.000596	CcSEcCtD
Furosemide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000174	0.000595	CcSEcCtD
Furosemide—Rash—Mycophenolic acid—systemic scleroderma	0.000173	0.00059	CcSEcCtD
Furosemide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000172	0.000589	CcSEcCtD
Furosemide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000586	CcSEcCtD
Furosemide—Headache—Mycophenolic acid—systemic scleroderma	0.000171	0.000586	CcSEcCtD
Furosemide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000584	CcSEcCtD
Furosemide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000584	CcSEcCtD
Furosemide—Nausea—Leflunomide—systemic scleroderma	0.00017	0.000582	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00017	0.000581	CcSEcCtD
Furosemide—Vision blurred—Prednisone—systemic scleroderma	0.000169	0.000578	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—systemic scleroderma	0.000169	0.000577	CcSEcCtD
Furosemide—Diarrhoea—Lisinopril—systemic scleroderma	0.000169	0.000576	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—systemic scleroderma	0.000166	0.000567	CcSEcCtD
Furosemide—Anaemia—Prednisone—systemic scleroderma	0.000166	0.000567	CcSEcCtD
Furosemide—Agitation—Prednisone—systemic scleroderma	0.000165	0.000563	CcSEcCtD
Furosemide—Dizziness—Lisinopril—systemic scleroderma	0.000163	0.000557	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—systemic scleroderma	0.000163	0.000557	CcSEcCtD
Furosemide—Nausea—Mycophenolic acid—systemic scleroderma	0.000163	0.000556	CcSEcCtD
Furosemide—Vertigo—Prednisone—systemic scleroderma	0.000161	0.000551	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—systemic scleroderma	0.000161	0.00055	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—systemic scleroderma	0.000161	0.000549	CcSEcCtD
Furosemide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000544	CcSEcCtD
Furosemide—Vomiting—Lisinopril—systemic scleroderma	0.000157	0.000536	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—systemic scleroderma	0.000156	0.000534	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—systemic scleroderma	0.000156	0.000532	CcSEcCtD
Furosemide—Rash—Lisinopril—systemic scleroderma	0.000155	0.000531	CcSEcCtD
Furosemide—Dermatitis—Lisinopril—systemic scleroderma	0.000155	0.000531	CcSEcCtD
Furosemide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00053	CcSEcCtD
Furosemide—Headache—Lisinopril—systemic scleroderma	0.000154	0.000528	CcSEcCtD
Furosemide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000522	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000152	0.000518	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—systemic scleroderma	0.00015	0.000512	CcSEcCtD
Furosemide—Erythema—Methotrexate—systemic scleroderma	0.00015	0.000512	CcSEcCtD
Furosemide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000505	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—systemic scleroderma	0.000147	0.000502	CcSEcCtD
Furosemide—Nausea—Lisinopril—systemic scleroderma	0.000146	0.0005	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisone—systemic scleroderma	0.000146	0.0005	CcSEcCtD
Furosemide—Shock—Prednisone—systemic scleroderma	0.000144	0.000492	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—systemic scleroderma	0.000144	0.000491	CcSEcCtD
Furosemide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000488	CcSEcCtD
Furosemide—Skin disorder—Prednisone—systemic scleroderma	0.000142	0.000486	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000142	0.000484	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—systemic scleroderma	0.000141	0.000483	CcSEcCtD
Furosemide—Anorexia—Prednisone—systemic scleroderma	0.00014	0.000477	CcSEcCtD
Furosemide—Anaemia—Methotrexate—systemic scleroderma	0.000139	0.000474	CcSEcCtD
Furosemide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000469	CcSEcCtD
Furosemide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000465	CcSEcCtD
Furosemide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000465	CcSEcCtD
Furosemide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000462	CcSEcCtD
Furosemide—Vertigo—Methotrexate—systemic scleroderma	0.000135	0.00046	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—systemic scleroderma	0.000134	0.000459	CcSEcCtD
Furosemide—Paraesthesia—Prednisone—systemic scleroderma	0.000131	0.000449	CcSEcCtD
Furosemide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000439	CcSEcCtD
Furosemide—Decreased appetite—Prednisone—systemic scleroderma	0.000127	0.000435	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000127	0.000433	CcSEcCtD
Furosemide—Fatigue—Prednisone—systemic scleroderma	0.000126	0.000431	CcSEcCtD
Furosemide—Constipation—Prednisone—systemic scleroderma	0.000125	0.000428	CcSEcCtD
Furosemide—Confusional state—Methotrexate—systemic scleroderma	0.000123	0.000422	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000122	0.000418	CcSEcCtD
Furosemide—Feeling abnormal—Prednisone—systemic scleroderma	0.000121	0.000412	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—systemic scleroderma	0.00012	0.00041	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00012	0.000409	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00012	0.000409	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—systemic scleroderma	0.000119	0.000406	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000118	0.000404	CcSEcCtD
Furosemide—Anorexia—Methotrexate—systemic scleroderma	0.000117	0.000399	CcSEcCtD
Furosemide—Urticaria—Prednisone—systemic scleroderma	0.000116	0.000398	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—systemic scleroderma	0.000116	0.000396	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—systemic scleroderma	0.000116	0.000396	CcSEcCtD
Furosemide—Hypotension—Methotrexate—systemic scleroderma	0.000114	0.000391	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—systemic scleroderma	0.00011	0.000376	CcSEcCtD
Furosemide—Somnolence—Methotrexate—systemic scleroderma	0.000109	0.000372	CcSEcCtD
Furosemide—Hypersensitivity—Prednisone—systemic scleroderma	0.000108	0.000369	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—systemic scleroderma	0.000106	0.000364	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000106	0.000361	CcSEcCtD
Furosemide—Fatigue—Methotrexate—systemic scleroderma	0.000105	0.000361	CcSEcCtD
Furosemide—Asthenia—Prednisone—systemic scleroderma	0.000105	0.000359	CcSEcCtD
Furosemide—Pain—Methotrexate—systemic scleroderma	0.000105	0.000358	CcSEcCtD
Furosemide—Pruritus—Prednisone—systemic scleroderma	0.000104	0.000354	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000101	0.000345	CcSEcCtD
Furosemide—Diarrhoea—Prednisone—systemic scleroderma	0.0001	0.000342	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.0001	0.000342	CcSEcCtD
Furosemide—Urticaria—Methotrexate—systemic scleroderma	9.72e-05	0.000332	CcSEcCtD
Furosemide—Dizziness—Prednisone—systemic scleroderma	9.68e-05	0.000331	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—systemic scleroderma	9.67e-05	0.000331	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—systemic scleroderma	9.67e-05	0.000331	CcSEcCtD
Furosemide—Vomiting—Prednisone—systemic scleroderma	9.31e-05	0.000318	CcSEcCtD
Furosemide—Rash—Prednisone—systemic scleroderma	9.23e-05	0.000316	CcSEcCtD
Furosemide—Dermatitis—Prednisone—systemic scleroderma	9.22e-05	0.000315	CcSEcCtD
Furosemide—Headache—Prednisone—systemic scleroderma	9.17e-05	0.000313	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—systemic scleroderma	9.01e-05	0.000308	CcSEcCtD
Furosemide—Asthenia—Methotrexate—systemic scleroderma	8.78e-05	0.0003	CcSEcCtD
Furosemide—Nausea—Prednisone—systemic scleroderma	8.7e-05	0.000297	CcSEcCtD
Furosemide—Pruritus—Methotrexate—systemic scleroderma	8.66e-05	0.000296	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—systemic scleroderma	8.37e-05	0.000286	CcSEcCtD
Furosemide—Dizziness—Methotrexate—systemic scleroderma	8.09e-05	0.000277	CcSEcCtD
Furosemide—Vomiting—Methotrexate—systemic scleroderma	7.78e-05	0.000266	CcSEcCtD
Furosemide—Rash—Methotrexate—systemic scleroderma	7.71e-05	0.000264	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—systemic scleroderma	7.71e-05	0.000263	CcSEcCtD
Furosemide—Headache—Methotrexate—systemic scleroderma	7.66e-05	0.000262	CcSEcCtD
Furosemide—Nausea—Methotrexate—systemic scleroderma	7.27e-05	0.000248	CcSEcCtD
